# Phase 3B-1 Characterization Tests Report

## Objective
Establish a regression safety net for `ProductMapper.toSummaryResponse()` prior to any refactoring. This ensures that the baseline logic (behaviors A-J) remains intact during subsequent changes.

## Work Performed
1. Created `backend/src/test/java/com/alahadattars/mapper/ProductMapperTest.java`.
2. Implemented tests covering:
   - **A. Attar-only product**: Default variant selection and min price for ATTAR context.
   - **B. Perfume-only product**: Default variant selection and min price for PERFUME context.
   - **C. Mixed variants - Explicit context**: Context-dependent resolution for unisex products.
   - **D. Shared image fallback**: Correct resolution to shared primary image (fallback 3).
   - **E. Type-specific primary preference**: Correct resolution to type-specific primary image (fallback 1).
   - **F. Without a primary image**: Correct resolution to type-specific non-primary based on displayOrder (fallback 2).
   - **G. DisplayOrder sorting**: Resolving the lowest `displayOrder` when multiple primary images exist.
   - **H. Missing/null image metadata**: Safely falling back to shared non-primary when image attributes are missing/whitespace.
   - **I. No images**: Null safety for thumbnail.
   - **J. Default Variant Logic**: Verifying that min price correctly identifies the default variant even when cheaper inactive variants exist.
   - **Null-safety Fallbacks**: Ensuring null products do not crash the mapper.

## Verification Results
- **Backend Tests**: `mvn clean test -DreuseForks=false` executed successfully. All 176 tests in the backend test suite passed, including the 11 new tests in `ProductMapperTest.java`.
- **Frontend Build**: `npx tsc --noEmit && npm run build` executed successfully without errors.
- **Git Status**: Only the new test file (`backend/src/test/java/com/alahadattars/mapper/ProductMapperTest.java`) and the report are untracked. No production code was modified.

## Conclusion
The baseline behaviors of `ProductMapper` are now successfully locked down. Phase 3B (Implementation) can proceed safely without regressions.
